LYZZ Capital
Venture capitalShanghai · Seed–Series A · 5 people tracked
Investment thesis
LYZZ Capital dedicates itself to healthcare investing across venture and private equity, backing talent, assets, and technologies on a global basis. The firm targets areas addressing unmet medical needs and large market potential, with a strong focus on China. Its team is drawn from leading pharmaceutical and biotech companies as well as Wall Street firms, combining scientific, medical, and financial expertise. With more than two decades of biotech investment experience and over fifteen years of activity in China, LYZZ invests out of both USD and RMB funds, seeking opportunities that connect global innovation with Chinese market demand.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from public directoriesWhat they invest in
from 5 of 13 portfolio companiesBiotech ×5Healthtech ×2AgTech ×1Deep Tech ×1New Materials ×1
HQs:United States×3
Investments · 13 tracked
founders shown can be your intro pathAlpha Biopharma (Chentai) is a pharmaceutical company developing innovative drugs from clinical research through commercialization.
BiotechHealthtech
Jumpcode Genomics develops programmable endonuclease enzymes for next-generation sequencing and PCR applications.
BiotechDeep TechSan Diego, US
David Michael Salter(Executive Officer, Director)Eugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)Joseph Lee(Director)
A product-focused bio-manufacturing company producing food ingredients and chemical materials using renewable carbon sources and green processes, with global R&D partnerships and manufacturing in China.
Moji Bio applies genetic engineering, computational biology, and artificial intelligence to develop biomanufacturing processes that produce chemical materials and agricultural additives from sustainable feedstocks.
AgTechBiotechNew Materials
QPEX Bio develops anti-infective drugs targeting antibiotic-resistant bacterial and fungal pathogens.
BiotechHealthtechSan Diego, US
Michael N. Dudley(Executive Officer, Director)Carol Gallagher(Director)Terry Gould(Director)Kevin Li(Director)Daniel Burgess(Director)
BoardDouglas Reed(Director)
Frequently asked questions
- What stage does LYZZ Capital invest at?
- LYZZ Capital invests at the Seed, Series A stages.
- What sectors does LYZZ Capital focus on?
- LYZZ Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is LYZZ Capital located?
- LYZZ Capital is headquartered in Shanghai, CN.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.